TruScreen Group Limited (TRU.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 670.19 Thousand NZD | 45.7% |
| 2023 | 459.99 Thousand NZD | -12.0% |
| 2022 | 522.74 Thousand NZD | 30.67% |
| 2021 | 400.03 Thousand NZD | -22.51% |
| 2020 | 516.22 Thousand NZD | -36.12% |
| 2019 | 808.11 Thousand NZD | 20884.77% |
| 2018 | -3888.00 NZD | -103.45% |
| 2017 | 112.58 Thousand NZD | -48.63% |
| 2016 | 219.16 Thousand NZD | -51.61% |
| 2015 | 452.87 Thousand NZD | 4384.83% |
| 2014 | 10.09 Thousand NZD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 177.39 Thousand NZD | -15.39% |
| 2024 Q3 | 404.89 Thousand NZD | 128.24% |
| 2024 FY | 670.19 Thousand NZD | 45.7% |
| 2024 Q2 | 177.39 Thousand NZD | 0.0% |
| 2024 Q4 | 404.89 Thousand NZD | 0.0% |
| 2023 Q2 | 228.4 Thousand NZD | 0.0% |
| 2023 Q3 | 209.65 Thousand NZD | -8.21% |
| 2023 Q1 | 228.4 Thousand NZD | -4.21% |
| 2023 FY | 459.99 Thousand NZD | -12.0% |
| 2023 Q4 | 209.65 Thousand NZD | 0.0% |
| 2022 Q4 | 238.45 Thousand NZD | 0.0% |
| 2022 FY | 522.74 Thousand NZD | 30.67% |
| 2022 Q3 | 238.45 Thousand NZD | -35.1% |
| 2022 Q2 | 367.4 Thousand NZD | 0.0% |
| 2022 Q1 | 367.4 Thousand NZD | 21.93% |
| 2021 Q1 | 319.41 Thousand NZD | 46.29% |
| 2021 FY | 400.03 Thousand NZD | -22.51% |
| 2021 Q2 | 319.41 Thousand NZD | 0.0% |
| 2021 Q4 | 301.33 Thousand NZD | 0.0% |
| 2021 Q3 | 301.33 Thousand NZD | -5.66% |
| 2020 Q3 | 218.34 Thousand NZD | -67.33% |
| 2020 Q2 | 668.35 Thousand NZD | 0.0% |
| 2020 FY | 516.22 Thousand NZD | -36.12% |
| 2020 Q4 | 218.34 Thousand NZD | 0.0% |
| 2020 Q1 | 668.35 Thousand NZD | 104.03% |
| 2019 Q3 | 327.57 Thousand NZD | -40.57% |
| 2019 Q1 | 551.15 Thousand NZD | 14.07% |
| 2019 Q2 | 551.15 Thousand NZD | -0.0% |
| 2019 Q4 | 327.57 Thousand NZD | 0.0% |
| 2019 FY | 808.11 Thousand NZD | 20884.77% |
| 2018 FY | -3888.00 NZD | -103.45% |
| 2018 Q3 | 483.19 Thousand NZD | 151.79% |
| 2018 Q4 | 483.19 Thousand NZD | 0.0% |
| 2018 Q1 | 191.9 Thousand NZD | 11.4% |
| 2018 Q2 | 191.9 Thousand NZD | -0.0% |
| 2017 Q2 | 280.33 Thousand NZD | 0.0% |
| 2017 Q4 | 172.26 Thousand NZD | 0.0% |
| 2017 FY | 112.58 Thousand NZD | -48.63% |
| 2017 Q3 | 172.26 Thousand NZD | -38.55% |
| 2017 Q1 | 280.33 Thousand NZD | -7.79% |
| 2016 Q1 | 390.94 Thousand NZD | -19.36% |
| 2016 FY | 219.16 Thousand NZD | -51.61% |
| 2016 Q3 | 304 Thousand NZD | -22.24% |
| 2016 Q4 | 304 Thousand NZD | 0.0% |
| 2016 Q2 | 390.95 Thousand NZD | 0.0% |
| 2015 Q2 | 62.13 Thousand NZD | -0.0% |
| 2015 Q3 | 484.79 Thousand NZD | 680.26% |
| 2015 FY | 452.87 Thousand NZD | 4384.83% |
| 2015 Q4 | 484.79 Thousand NZD | 0.0% |
| 2015 Q1 | 62.13 Thousand NZD | 0.0% |
| 2014 FY | 10.09 Thousand NZD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | 80.947% |
| Adherium Limited | -640.83 Thousand AUD | 204.581% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 98.759% |
| Atomo Diagnostics Limited | 1.43 Million AUD | 53.352% |
| Anteris Technologies Ltd | 2.51 Million AUD | 73.375% |
| Control Bionics Limited | 3.67 Million AUD | 81.752% |
| CardieX Limited | 10.1 Million AUD | 93.37% |
| Compumedics Limited | 26.06 Million AUD | 97.429% |
| Cochlear Limited | 1.69 Billion AUD | 99.96% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 94.1% |
| Cyclopharm Limited | 4.49 Million AUD | 85.098% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 94.026% |
| Nova Eye Medical Limited | 20.19 Million AUD | 96.681% |
| HeraMED Limited | -504.09 Thousand AUD | 232.95% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 133.629% |
| ImpediMed Limited | 9 Million AUD | 92.558% |
| InhaleRx Limited | 1.2 Million AUD | 44.338% |
| LBT Innovations Limited | -2.91 Million AUD | 122.975% |
| Micro-X Limited | 5.73 Million AUD | 88.318% |
| Neurotech International Limited | -5867.00 AUD | 11523.078% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -1104.688% |
| PolyNovo Limited | 36.08 Million AUD | 98.143% |
| Respiri Limited | 456.91 Thousand AUD | -46.678% |
| SomnoMed Limited | 55.13 Million AUD | 98.784% |
| Universal Biosensors, Inc. | 4.28 Million AUD | 84.359% |
| Uscom Limited | 3.11 Million AUD | 78.49% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 347.198% |